Literature DB >> 29712989

A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone.

Mrinal M Patnaik1, Terra L Lasho2, Katherine P Hoversten2, Christy M Finke2, Rhett P Ketterling3, Curtis A Hanson3, Naseema Gangat2, Ayalew Tefferi2, Animesh Pardanani2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29712989     DOI： 10.1038/s41375-018-0121-1

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  10 in total

Review 1.  Laboratory Evaluation and Pathological Workup of Neoplastic Monocytosis - Chronic Myelomonocytic Leukemia and Beyond.

Authors:  Siba El Hussein; Joseph D Khoury; L Jeffrey Medeiros; Sanam Loghavi
Journal:  Curr Hematol Malig Rep       Date:  2021-05-04       Impact factor: 3.952

Review 2.  Recent Updates on Chronic Myelomonocytic Leukemia.

Authors:  Sanam Loghavi; Joseph D Khoury
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

Review 3.  Chronic Myelomonocytic Leukemia: Hematopathology Perspective.

Authors:  Siba El Hussein; Sa A Wang; Naveen Pemmaraju; Joseph D Khoury; Sanam Loghavi
Journal:  J Immunother Precis Oncol       Date:  2021-06-18

4.  Phenotypic characterization of leukemia-initiating stem cells in chronic myelomonocytic leukemia.

Authors:  Gregor Eisenwort; Irina Sadovnik; Alexandra Keller; Daniel Ivanov; Barbara Peter; Daniela Berger; Gabriele Stefanzl; Karin Bauer; Katharina Slavnitsch; Georg Greiner; Karoline V Gleixner; Wolfgang R Sperr; Michael Willmann; Heinz Sill; Peter Bettelheim; Klaus Geissler; Michael Deininger; Thomas Rülicke; Peter Valent
Journal:  Leukemia       Date:  2021-03-30       Impact factor: 12.883

5.  Progression, transformation, and unusual manifestations of myelodysplastic syndromes and myelodysplastic-myeloproliferative neoplasms: lessons learned from the XIV European Bone Marrow Working Group Course 2019.

Authors:  Konnie Hebeda; Ludmila Boudova; Christine Beham-Schmid; Attilio Orazi; Hans-Michael Kvasnicka; Umberto Gianelli; Alexandar Tzankov
Journal:  Ann Hematol       Date:  2020-10-31       Impact factor: 3.673

6.  Splenectomy in patients with chronic myelomonocytic leukemia: Indications, histopathological findings and clinical outcomes in a single institutional series of thirty-nine patients.

Authors:  Prateek Pophali; Pedro Horna; Terra L Lasho; Christy M Finke; Rhett P Ketterling; Naseema Gangat; David Nagorney; Ayalew Tefferi; Mrinal M Patnaik
Journal:  Am J Hematol       Date:  2018-10-05       Impact factor: 10.047

Review 7.  Mutations in chronic myelomonocytic leukemia and their prognostic relevance.

Authors:  J Jian; Y Qiao; Y Li; Y Guo; H Ma; B Liu
Journal:  Clin Transl Oncol       Date:  2021-04-16       Impact factor: 3.405

8.  How I diagnose and treat chronic myelomonocytic leukemia.

Authors:  Mrinal M Patnaik
Journal:  Haematologica       Date:  2022-07-01       Impact factor: 11.047

Review 9.  Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions.

Authors:  Peter Valent; Attilio Orazi; Michael R Savona; Mrinal M Patnaik; Francesco Onida; Arjan A van de Loosdrecht; Detlef Haase; Torsten Haferlach; Chiara Elena; Lisa Pleyer; Wolfgang Kern; Tea Pemovska; Gregory I Vladimer; Julie Schanz; Alexandra Keller; Michael Lübbert; Thomas Lion; Karl Sotlar; Andreas Reiter; Theo De Witte; Michael Pfeilstöcker; Klaus Geissler; Eric Padron; Michael Deininger; Alberto Orfao; Hans-Peter Horny; Peter L Greenberg; Daniel A Arber; Luca Malcovati; John M Bennett
Journal:  Haematologica       Date:  2019-05-02       Impact factor: 9.941

Review 10.  Recent advances in the understanding and therapeutic management of mastocytosis.

Authors:  Julien Rossignol; Laura Polivka; Leila Maouche-Chrétien; Laurent Frenzel; Patrice Dubreuil; Olivier Hermine
Journal:  F1000Res       Date:  2019-11-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.